|1.||Lever, Mark S: 1 article (08/2012)|
|2.||Smither, Sophie J: 1 article (08/2012)|
|3.||Hoenderop, Joost G J: 1 article (03/2011)|
|4.||Bindels, René J M: 1 article (03/2011)|
|5.||Ferrè, Silvia: 1 article (03/2011)|
|6.||Fishbein, Martin: 1 article (04/2008)|
|7.||Hennessy, Michael: 1 article (04/2008)|
|8.||Yzer, Marco: 1 article (04/2008)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
04/01/2008 - "We use data from the AIDS Community Demonstration Projects (ACDP) to illustrate this important idea. "
01/26/1985 - "Britain's Advisory Committee on Dangerous Pathogens (ACDP) has published interim guidelines to safeguard the health and safety of workers who come in contact with acquired immunodeficiency syndrome (AIDS) patients and those who work with the HTLV-III virus in clinical and research laboratories. "
|2.||Angelman Syndrome (Syndrome, Angelman)
03/01/2011 - "In addition to the well known transient receptor potential channel melastatin (TRPM), members 6 and 7, and the mitochondrial transporter Mrs2, additional Mg-transporting protein families can be acknowledged including the magnesium (Mag) transporters, the solute carrier (SLC) family 41 members, ancient conserved domain proteins (ACDP), nonimprinted in Prader-Willi/Angelman syndrome (NIPA) proteins, membrane Mg transporters (MMgT) and huntingtin-interacting protein 14 (HIP14). "
|3.||Marburg Virus Disease
08/01/2012 - "Porton Down houses two separate sites capable of conducting high containment research on ACDP (Advisory Committee on Dangerous Pathogens) Hazard Group 4 agents: the Defence Science and Technology Laboratory (Dstl) and the Health Protection Agency (HPA), and filovirus research has been performed at Porton Down since the first Marburg virus disease outbreak in 1967. "
|4.||Immunoproliferative Small Intestinal Disease
|1.||Proteins (Proteins, Gene)
|2.||Membrane Proteins (Integral Membrane Proteins)